Expand OGEN Menu
OGEN MENU

OGEN Stock Posts


OGEN #Oragenics stock declines -44.9% in premarket,

Premarket Decliner

OGEN Oragenics2.45-0.71-22.5%

Premarket:1.35-1.10 (-44.9%)

Oragenics Announces Pricing of Public Offering

Business WireTue, 27-Feb 9:25 PM
OGEN #Oragenics stock increases 59.8% in premarket,

Premarket Gainer

OGEN Oragenics0.84+0.02+3.0%

Premarket:1.35+0.50 (+59.8%)

Oragenics Enters into Material Transfer Agreement with Biodextris for Mucosal Adjuvant for Intranasal COVID-19 Vaccine

Business WireTue, 9-Mar 7:00 AM
OGEN #Oragenics stock increases 83.1% in premarket,

Premarket Gainer

OGEN Oragenics0.62+0.04+6.9%

Premarket:1.13+0.51 (+83.1%)

Oragenics Enters Into Material Transfer Agreement With Adjuvance Technologies for COVID-19 Vaccine Adjuvant

Business WireThu, 7-Jan 7:00 AM
OGEN #OragenicsInc. stock increases 44.1% in premarket,

Premarket Gainer

OGEN Oragenics Inc.1.36-0.11-7.5%

Premarket:1.96+0.60 (+44.1%)

Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing Antibodies

Business WireWed, 22-Jul 7:30 AM
OGEN #OragenicsInc. stock increases 45.8% in premarket,

Premarket Gainer

OGEN Oragenics Inc.1.20+0.01+0.8%

Premarket:1.75+0.55 (+45.8%)

Oragenics Reports Positive Interim Safety Analysis Results from Its Phase 2 Clinical Trial of AG013 for Oral Mucositis

Business WireWed, 30-May 7:30 AM
Load Earlier Posts